Mucofizz 200 mg tablets.
PDF Leaflet Revision Date: 14 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Mucolytic for non-infective secretions in cystic fibrosis and respiratory conditions.
Dosage (summary)
Adults: 1 tablet 2-3 times daily for max 14 days.
Special Populations
- Asthmatic patients
- Elderly with respiratory insufficiency
- Cirrhosis
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Antitussives
- Tetracycline (except doxycycline)
- Nitroglycerin
- Carbamazepine
Contraindications
- Hypersensitivity to acetylcysteine
- Pregnancy
- Lactation
- Children under 2 years
- Active peptic ulceration
Common side effects
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Hypersensitivity reactions
Counselling Points
- Dissolve tablet in water before use
- Do not exceed 14 days without consulting a doctor
- Monitor for skin reactions
Serious warnings
- Severe skin reactions (Stevens-Johnson syndrome)
- Bronchospasm in asthmatics
Important Disclaimer
The Mucofizz 200 mg tablets. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
